Viatris Inc Ordinary Shares VTRS 深沪

已收盘 08-01 16:00:00 美东时间

8.81

+0.070

+0.80%

华盛通

立即下载

最高8.87
今开8.72
成交量 673.06万股
最低 8.625
昨收 8.74
总市值 103.43亿
52周最高 13.31
市盈率 ^静 --
换手率 0.57%
52周最低 6.73
委比 52.44%
总股本 11.74亿
历史最高 16.85
量比 0.99
振幅 2.80%
历史最低 6.73
每手 1
风险率 1.06%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Bristol-Myers Squibb Earnings Preview

Bristol-Myers Squibb (NYSE:BMY) is set to give its latest quarterly earnings re...

07-30 22:02
Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Teva anticipates EBITDA recovery post-2025 as Austedo and Uzedy grow and generic Revlimid faces rising competition.

07-30 02:44
Seeking value? 10 standout stocks according to SA metrics

With Wall Street trading at all-time highs, some investors are turning to value-oriented positions as a way to uncover overlooked opportunities and add a layer of stability amid elevated valuations. A...

07-29 23:58
Theravance Biopharma to Report Second Quarter 2025 Financial Results on August 12, 2025

DUBLIN, July 28, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2025 financial results and provide a business update after market close on Tues...

07-28 18:00
Judge Rules Mylan Did Not Infringe Novo Nordisk Patent In Wegovy Generic Case

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, contributory, and induced infringement claims.

07-25 23:28
Amneal Pharmaceuticals announces unaudited preliminary Q2 revenue between $720M and $730M

Amneal Pharmaceuticals (NASDAQ:AMRX) announced on Monday unaudited preliminary Q2 revenue of $720 million to $730 million, versus consensus revenue estimates of $748.18M, an increase of approximately ...

07-21 20:23
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis

PITTSBURGH, July 18, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that a randomized, double-masked, vehicle-controlled, Phase 3 study to eva...

07-18 18:59
Verisk acquires SuranceBay for $162.5M

Data analytics and technology provider Verisk Analytics (NASDAQ:VRSK) announced on Thursday the acquisition of SuranceBay for a cash consideration of $162.5M. SuranceBay provides producer licensing, o...

07-17 21:44
Otsuka’s PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting

The FDA staffers on Wednesday cited efficacy issues related to a combination regimen involving brexpiprazole, an antipsychotic medication developed by Otsuka Pharma (OTCPK:OTSKY) and H. Lundbeck (OTCP...

07-17 02:25
ViiV expands license to produce generic Apretude in low-income countries

ViiV Healthcare, which is majority owned by GSK (NYSE:GSK), said it will expand a licensing agreement with the Medicines Patent Pool that will allow manufacturers to produce generic Apretude (cabotegr...

07-14 23:58

派息除权日	每股总股息	派息日期
2025-05-23	0.12	2025-06-16
2025-03-10	0.12	2025-03-18
2024-11-22	0.12	2024-12-13
2024-08-23	0.12	2024-09-13
2024-05-23	0.12	2024-06-14
2024-03-08	0.12	2024-03-18
2023-11-22	0.12	2023-12-15
2023-08-23	0.12	2023-09-15
2023-05-23	0.12	2023-06-16
2023-03-08	0.12	2023-03-17
2022-11-22	0.12	2022-12-16
2022-08-23	0.12	2022-09-16
2022-05-23	0.12	2022-06-16
2022-02-23	0.12	2022-03-16
2021-11-22	0.11	2021-12-16
2021-08-23	0.11	2021-09-16
2021-05-21	0.11	2021-06-16
2007-06-27	0.06	2007-07-16
2007-03-28	0.06	2007-04-16
2006-12-27	0.06	2007-01-16
2006-09-27	0.06	2006-10-16
2006-06-28	0.06	2006-07-14
2006-03-29	0.06	2006-04-17
2005-12-28	0.06	2006-01-13
2005-09-28	0.06	2005-10-17
2005-06-28	0.06	2005-07-15
2005-03-29	0.03	2005-04-15
2004-12-29	0.03	2005-01-14
2004-09-28	0.03	2004-10-15
2004-06-28	0.03	2004-07-15
2004-03-29	0.03	2004-04-15
2003-12-29	0.03	2004-01-15
2003-09-26	0.03	2003-10-15
2003-06-26	0.03	2003-07-15
2003-03-27	0.03	2003-04-15
2002-12-27	0.05	2003-01-15
2002-09-26	0.04	2002-10-15
2002-06-26	0.04	2002-07-15
2002-03-26	0.04	2002-04-15
2001-12-27	0.04	2002-01-15
2001-09-26	0.04	2001-10-15
2001-06-27	0.04	2001-07-16
2001-03-28	0.04	2001-04-16
2000-12-27	0.04	2001-01-15
2000-09-27	0.04	2000-10-15
2000-06-28	0.04	2000-07-15
2000-03-29	0.04	2000-04-15
1999-12-29	0.04	2000-01-14
1999-09-28	0.04	1999-10-15
1999-06-28	0.04	1999-07-15
1999-03-29	0.04	1999-04-15
1998-12-29	0.04	1999-01-15
1998-09-28	0.04	1998-10-15
1998-06-26	0.04	1998-07-15
1998-03-30	0.04	1998-04-15
1997-12-29	0.04	1998-01-15
1997-09-26	0.04	1997-10-15
1997-06-26	0.04	1997-07-15
1997-03-26	0.04	1997-04-15
1996-12-30	0.04	1997-01-15
1996-09-26	0.04	1996-10-15
1996-06-26	0.04	1996-07-15
1996-03-27	0.04	1996-04-15
1995-12-27	0.04	1996-01-15
1995-09-27	0.04	1995-10-13
1995-06-29	0.05	1995-07-14
1995-03-27	0.05	1995-04-13
1994-12-23	0.05	1995-01-13
1994-09-26	0.05	1994-10-14
1994-06-24	0.04	1994-07-15
1994-03-25	0.04	1994-04-15
1993-12-27	0.04	1994-01-14
1993-09-24	0.04	1993-10-15
1993-06-24	0.03	1993-07-15
1993-03-25	0.03	1993-04-15
1992-12-24	0.03	1993-01-15
1992-09-24	0.03	1992-10-15
1992-06-24	0.05	1992-07-15
1992-03-25	0.05	1992-04-15
1991-12-24	0.05	1992-01-15
1991-09-24	0.05	1991-10-15
1991-06-24	0.05	1991-07-15
1991-03-22	0.05	1991-04-15
1990-12-24	0.05	1991-01-15
1990-09-24	0.05	1990-10-15
1990-06-25	0.05	1990-07-16
1989-12-22	0.05	1990-01-15
1989-06-26	0.05	1989-07-17
1988-12-23	0.05	1989-01-16
1988-06-29	0.05	1988-07-15
1987-12-24	0.05	1988-01-15
1987-06-24	0.05	1987-07-15
1986-12-24	0.05	1987-01-15
1986-06-24	0.05	1986-07-15
1985-12-27	0.05	1986-01-15
1985-06-24	0.05	1985-07-19
1984-12-24	0.10	1985-01-15
1984-05-21	0.05	1984-06-13
1983-07-11	0.05	1983-08-12
1981-11-16	1.00	1981-11-13

公司名称	Viatris Inc Ordinary Shares
行业分类	--
业务描述	Viatris Inc.于2019年2月14日在特拉华州成立。该公司的业务在医药产品的商业化和制造方面处于全球领先地位，拥有20个全球公认的医药品牌以及一个美国的仿制药平台Greenstone。

Viatris Inc Ordinary Shares VTRS 深 沪

8.81

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Viatris Inc Ordinary Shares VTRS 深沪